Transcatheter Left Atrial Appendage Closure: Devices Available, Pitfalls, Advantages, and Future Directions
Transcatheter left atrial appendage closure has emerged as a non-pharmacological alternative to long-term anticoagulation for stroke prevention in appropriately selected patients with AF. In this concise review article, the Food and Drug Administration-approved and some other left atrial appendage c...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2023-05-01
|
| Series: | US Cardiology Review |
| Online Access: | https://www.uscjournal.com/articleindex/usc.2022.37 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850104159602212864 |
|---|---|
| author | Chirag Bavishi |
| author_facet | Chirag Bavishi |
| author_sort | Chirag Bavishi |
| collection | DOAJ |
| description | Transcatheter left atrial appendage closure has emerged as a non-pharmacological alternative to long-term anticoagulation for stroke prevention in appropriately selected patients with AF. In this concise review article, the Food and Drug Administration-approved and some other left atrial appendage closure devices that are under investigation are discussed. Currently, Watchman Flx and Amplatzer Amulet are the only two devices that have been approved for commercial use by the Food and Drug Administration. A brief overview of device designs, clinical data on efficacy and safety, major limitations of left atrial appendage closure devices, and perspectives on future direction are provided. The current generation of devices is effective; however, efforts should continue on innovations and refinement of device technology. |
| format | Article |
| id | doaj-art-b806a320d61a489998b57bbc21bc9613 |
| institution | DOAJ |
| issn | 1758-3896 1758-390X |
| language | English |
| publishDate | 2023-05-01 |
| publisher | Radcliffe Medical Media |
| record_format | Article |
| series | US Cardiology Review |
| spelling | doaj-art-b806a320d61a489998b57bbc21bc96132025-08-20T02:39:23ZengRadcliffe Medical MediaUS Cardiology Review1758-38961758-390X2023-05-011710.15420/usc.2022.37Transcatheter Left Atrial Appendage Closure: Devices Available, Pitfalls, Advantages, and Future DirectionsChirag Bavishi0Division of Cardiology, University of Missouri School of Medicine, Columbia, MOTranscatheter left atrial appendage closure has emerged as a non-pharmacological alternative to long-term anticoagulation for stroke prevention in appropriately selected patients with AF. In this concise review article, the Food and Drug Administration-approved and some other left atrial appendage closure devices that are under investigation are discussed. Currently, Watchman Flx and Amplatzer Amulet are the only two devices that have been approved for commercial use by the Food and Drug Administration. A brief overview of device designs, clinical data on efficacy and safety, major limitations of left atrial appendage closure devices, and perspectives on future direction are provided. The current generation of devices is effective; however, efforts should continue on innovations and refinement of device technology.https://www.uscjournal.com/articleindex/usc.2022.37 |
| spellingShingle | Chirag Bavishi Transcatheter Left Atrial Appendage Closure: Devices Available, Pitfalls, Advantages, and Future Directions US Cardiology Review |
| title | Transcatheter Left Atrial Appendage Closure: Devices Available, Pitfalls, Advantages, and Future Directions |
| title_full | Transcatheter Left Atrial Appendage Closure: Devices Available, Pitfalls, Advantages, and Future Directions |
| title_fullStr | Transcatheter Left Atrial Appendage Closure: Devices Available, Pitfalls, Advantages, and Future Directions |
| title_full_unstemmed | Transcatheter Left Atrial Appendage Closure: Devices Available, Pitfalls, Advantages, and Future Directions |
| title_short | Transcatheter Left Atrial Appendage Closure: Devices Available, Pitfalls, Advantages, and Future Directions |
| title_sort | transcatheter left atrial appendage closure devices available pitfalls advantages and future directions |
| url | https://www.uscjournal.com/articleindex/usc.2022.37 |
| work_keys_str_mv | AT chiragbavishi transcatheterleftatrialappendageclosuredevicesavailablepitfallsadvantagesandfuturedirections |